Pricing Log in Create free account

Arcturus Therapeutics Holdings Inc. (ARCT) vs C4 Therapeutics, Inc. (CCCC)

Arcturus Therapeutics Holdings Inc. and C4 Therapeutics, Inc. are both Biotechnology companies. Arcturus Therapeutics Holdings Inc. and C4 Therapeutics, Inc. are of similar size ($342.0M and $320.3M). C4 Therapeutics, Inc. grew revenue faster over the last twelve months: 2.33% against −76.0%. C4 Therapeutics, Inc. has the higher net margin (−289.4% vs −317.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, C4 Therapeutics, Inc. leads on 9 and Arcturus Therapeutics Holdings Inc. on 6.

Valuation

Metric ARCT CCCC Biotechnology median
P/E n/m n/m 8.50
P/S 10.01 10.33 9.71
P/B 1.71 1.46 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 6.06 3.63 9.21
Earnings yield (32.01%) (36.10%) (33.15%)
Free cash flow yield (24.76%) (23.59%) (25.50%)

Profitability

Metric ARCT CCCC Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (348.32%) (318.97%) 0.00%
Net margin (317.61%) (289.44%) 0.00%
Free cash flow margin (247.79%) (243.71%) 0.00%
Return on equity (46.31%) (48.14%) (56.36%)
Return on assets (34.96%) (30.92%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARCT CCCC Biotechnology median
Revenue growth (TTM) (75.95%) 2.33% 6.02%
EPS growth (last fiscal year) 20.00% 16.45% 30.26%
Revenue growth, 5-year CAGR 53.78% 1.61% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARCT CCCC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.88 5.45 4.72
Net debt to EBITDA 3.15 2.14 0.96

Dividend

Metric ARCT CCCC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ARCT CCCC Biotechnology median
Market cap 320.32m 342.01m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack